Intravenous immunoglobulin treatment in children with guillain-barre syndrome
Scandinavian Journal of Infectious Diseases, cilt.27, sa.3, ss.241-243, 1995 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 27 Sayı: 3
- Basım Tarihi: 1995
- Doi Numarası: 10.3109/00365549509019016
- Dergi Adı: Scandinavian Journal of Infectious Diseases
- Derginin Tarandığı İndeksler: Scopus
- Sayfa Sayıları: ss.241-243
- Ondokuz Mayıs Üniversitesi Adresli: Evet
Özet
Guillain-Barre syndrome is an acquired demyelinating polyneuropathy that is presumed to be immune-mediated. On the basis of this assumption, intravenous immunoglobulin (IVIG) has been used in the treatment of Guillain-Barre syndrome in recent years and found to be effective. To test this we performed a randomized study in patients with Guillain-Barre syndrome by giving IVIG (1 g/kg body weight per day over 2 consecutive days) in 9 children who were compared with 9 patients who were observed but not given specific therapy. We concluded that intravenous immunoglobulin is a safe and effective treatment for childhood Guillain-Barre syndrome which shortens the time to recovery. © 1995 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.